Literature DB >> 8294839

The presence of myofibroblasts in the dermis of patients with Dupuytren's contracture. A possible source for recurrence.

B G McCann1, A Logan, H Belcher, A Warn, R M Warn.   

Abstract

Samples of skin and underlying cord obtained at dermofasciectomy for Dupuytren's contracture have been examined for the presence of smooth muscle alpha-actin (SM alpha-actin), a marker for myofibroblasts. 15 of the 20 samples stained positively for SM alpha-actin corresponding with areas of hypercellular Dupuytren's tissue. In 12 of these 15 samples SM alpha-actin-positive hypercellular Dupuytren's tissue extended into the dermis, in three cases reaching the epidermis. In eight samples, diffusely distributed cells positive for SM alpha-actin and resembling fibroblasts were seen in the dermis. These cells appeared to be separate from the Dupuytren's foci. The presence of hypercellular foci and isolated fibroblasts positive for SM alpha-actin within the dermis may explain the high recurrence rate of Dupuytren's disease after fasciectomy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8294839     DOI: 10.1016/0266-7681(93)90029-f

Source DB:  PubMed          Journal:  J Hand Surg Br        ISSN: 0266-7681


  5 in total

1.  A mathematical model for fibro-proliferative wound healing disorders.

Authors:  L Olsen; J A Sherratt; P K Maini
Journal:  Bull Math Biol       Date:  1996-07       Impact factor: 1.758

2.  Identification of mesenchymal stem cells in perinodular fat and skin in Dupuytren's disease: a potential source of myofibroblasts with implications for pathogenesis and therapy.

Authors:  Syed Amir Iqbal; Christopher Manning; Farhatullah Syed; Venkatesh Kolluru; Mike Hayton; Stewart Watson; Ardeshir Bayat
Journal:  Stem Cells Dev       Date:  2011-07-19       Impact factor: 3.272

3.  The Rationale for Treating the Nodule in Dupuytren's Disease.

Authors:  Lynn D Ketchum
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-01-08

4.  Use of Acellular Dermal Matrix Following Fasciectomy for the Treatment of Dupuytren's Disease.

Authors:  Don Hoang; Patrick Steven; Vivi W Chen; Ashley Stasiak; Myles Cohen; David A Kulber
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-05-23

5.  First identification of resident and circulating fibrocytes in Dupuytren's disease shown to be inhibited by serum amyloid P and Xiapex.

Authors:  Syed Amir Iqbal; Michael John Hayton; James Stewart Watson; Piotr Szczypa; Ardeshir Bayat
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.